by in
Entry Author Date Location
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network 08/26/11 Seattle
Dendreon Adds Ex-ImClone CEO to Board 08/22/11 Seattle
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
An Open Letter to Dendreon’s Chairman 08/05/11 Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall 08/03/11 Seattle
Dendreon Misses Street Expectations, Plans Layoffs, Backs Away from Bullish Forecast 08/03/11 Seattle
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $93,000 Prostate Cancer Drug 06/30/11 Seattle
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News 06/30/11 Seattle
Dendreon Gets FDA Nod for New LA Cancer Drug Factory 06/29/11 Seattle
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer 05/24/11 Seattle
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News 05/05/11 Seattle
Dendreon Gets $28M Revenue in Q1 05/02/11 Seattle
Dendreon Faces Internet-Fueled Shareholder Uprising, Led by a Little Guy in Kansas 04/01/11 Seattle
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug 03/30/11 Seattle
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End 03/11/11 Seattle
Dendreon Gets FDA Green Light for NJ Factory 03/10/11 Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building 03/01/11 Seattle
Dendreon Scopes Out Downtown Seattle Headquarters 02/18/11 Seattle
Dendreon Rakes in $540M to Seize Opportunity for Provenge in U.S., Europe 01/14/11 Seattle
Dendreon Seeks $500M Debt Deal 01/13/11 Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News 01/13/11 Seattle
Dendreon Plans to Go It Alone in Europe, Build Provenge Factory in Germany 01/07/11 Seattle
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011 12/30/10 San Francisco
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News 11/24/10 Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch 11/18/10 Seattle
Page 2 of 6 « previous page · next page »